反応式
C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].[Cl:15][C:16]1[CH:35]=[CH:34][C:19]2[O:20][C:21]3[CH:33]=[CH:32][CH:31]=[CH:30][C:22]=3[C@@H:23]3[C@H:28]([NH2:29])[CH2:27][CH2:26][CH2:25][N:24]3[C:18]=2[CH:17]=1.[CH:36](=O)[CH:37]([CH3:39])[CH3:38]>C(Cl)Cl>[CH3:36][CH:37]([CH3:39])[CH2:38][NH:29][C@H:28]1[C@@H:23]2[N:24]([C:18]3[CH:17]=[C:16]([Cl:15])[CH:35]=[CH:34][C:19]=3[O:20][C:21]3[CH:33]=[CH:32][CH:31]=[CH:30][C:22]=32)[CH2:25][CH2:26][CH2:27]1参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
After 10 min. stirring sodium triacetoxyborohydride (11 mg, 0.05 mmol) was added to trans-7-chloro-2,3,4,14b-tetrahydro-1H-dibenzo[b,f]pyrido[1,2-d][1,4]oxazepine-1-amine (10 mg, 0.03 mmol) and isobutyraldehyde (3.45 mg, 0.03 mmol) in 1 mL of CH2Cl2 (pH=4). The resulting mixture was stirred at room temperature for 18 h. The mixture was evaporated and chromatographed on silica. Elution with CH2Cl2/methanol 8:2 gave trans-N-(2-methylpropyl)-7-chloro-2,3,4,14b-tetrahydro-1H-dibenzo[b,f]pyrido[1,2-d][1,4]oxazepine-1-amine (13 mg, 100%). Data: (m/z)=357 (M+H)+.
後処理
- customThe mixture was evaporated
- customchromatographed on silica
- washElution with CH2Cl2/methanol 8:2
出典と根拠
- ORDレコード
- ord-5b40de8771ea4a59a7d98d1340ebaefd
- 出典データセット
- uspto-grants-2010_06
- 特許番号
- US07737136B2
関連ノート
読み込み中…